Manulife Financial (MFC) Earnings Date & Reports

Key Takeaways

• Manulife reported second-quarter 2026 core earnings of C$1.92 billion, up 12% year over year, with core EPS (earnings per share) of C$1.09, up 16%.
• Net income attributable to shareholders rose 17% to C$2.11 billion.
• Core EPS came in modestly ahead of the consensus estimate of roughly C$1.08.
• Asia was the standout driver, with core earnings up 21%, while Global WAM (Wealth and Asset Management) core earnings rose 9%.
• Core ROE (return on equity) reached 16.3%, up 130 basis points, and the CSM (contractual service margin) balance grew 20% year over year.
• Canada remained a soft spot, with core earnings down 10% on unfavorable claims experience.

Earnings Context and Why It Matters

Manulife Financial's quarterly earnings offer a broad read on the global life insurance and wealth management landscape, spanning Asia, Canada, and the United States. The second-quarter report matters because it tests whether the company's high-growth Asian franchise can keep offsetting softer results in more mature markets and rising expense pressures in its Canadian group insurance business. Investors also watch core metrics such as core EPS, new business value, and return on equity to gauge the durability of Manulife's multi-year push toward higher-quality growth, stronger margins, and disciplined capital deployment through dividends and share buybacks.

Reported Results

Manulife Financial reported second-quarter 2026 core earnings of C$1.92 billion, an increase of 12% from C$1.726 billion in the prior-year period. Core EPS rose 16% to C$1.09, modestly ahead of the consensus estimate of approximately C$1.08. Net income attributable to shareholders climbed 17% to C$2.11 billion, while reported EPS increased 22% to C$1.20.

Growth was led by Asia, where core earnings increased 21%, supported by continued business growth and the net positive impact of 2025 actuarial updates. Global WAM core earnings rose 9%, driven by higher net fee income and contributions from the Manulife Comvest business. Canada core earnings declined 10%, reflecting unfavorable claims experience in group insurance.

Key operating metrics strengthened across the board. APE (annualized premium equivalent) sales rose 21% to C$2.698 billion, new business CSM grew 16% to C$1.024 billion, and NBV (new business value) increased 10% to C$929 million. Core ROE reached 16.3%, up 130 basis points, while adjusted book value per common share rose 15% to C$41.12. The company also highlighted a 20% year-over-year increase in its CSM balance, signaling stronger future earnings capacity.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Manulife Financial and its peers, the AI Screener can help surface relevant opportunities across the insurance and asset management sectors.

Market Reaction and Investor Sentiment

Investors responded positively to the results, with Manulife shares trading modestly higher following the report as the company's core EPS beat and double-digit Asia growth reinforced confidence in its growth strategy. The broad-based operational improvement, combined with a higher core ROE and a growing CSM balance, supported the view that earnings quality is strengthening rather than relying on one-time items. Still, sentiment remains balanced by ongoing concerns around Canadian group insurance claims and net outflows in parts of the Global WAM business, which continue to temper enthusiasm heading into the back half of the fiscal year.

Forward Outlook and Key Factors to Monitor

Manulife indicated it remains on track toward its medium-term targets, including core ROE above 18% and an expense efficiency ratio below 45%. The company ended the quarter at a 44.5% efficiency ratio, and its ongoing share buyback program remains a key lever on the path to that ROE objective.

Investors should watch several factors in the coming quarters. First, the sustainability of Asia's growth will be closely tracked, particularly APE sales, new business CSM, and NBV across Hong Kong, Japan, and Singapore. Second, the Canadian group insurance segment's claims experience will be monitored for signs of normalization, as elevated long-term disability claims weighed on recent results.

Capital and balance-sheet metrics also warrant attention. Manulife's LICAT (Life Insurance Capital Adequacy Test) ratio stood at 136%, comfortably above regulatory targets, supporting continued shareholder returns through dividends and buybacks. Finally, investment spreads in the U.S. and the ongoing eMPF (Mandatory Provident Fund) transition in Hong Kong remain areas that could influence fee income and Global WAM earnings in future periods.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations